Harvard Bioscience Inc Cash Flow Quality Index

Latest as of December 2024: 95.83x

Harvard Bioscience Inc cash flow quality index. Harvard Bioscience Inc (HBIO) has a Cash Flow Quality Index of 95.83x as of December 2024. Operating cash flow of $1.73 Million exceeds net income of $18.00K, indicating high earnings quality where cash backs reported profits. Explore Harvard Bioscience Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

95.83x
Operating CF / Net Income

Operating Cash Flow

$1.73 Million
USD

Net Income

$18.00K
USD

Data as of

Dec 2024
Most recent filing

Cash Flow Quality Index of Harvard Bioscience Inc (2002–2014)

Cash flow quality index of Harvard Bioscience Inc from 2002 to 2014. Historical Cash Flow Quality Index for Harvard Bioscience Inc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Harvard Bioscience Inc (HBIO) balance sheet quality index to measure how much of total assets are equity-financed.

Harvard Bioscience Inc Cash Flow Quality Index by Year (2002–2014)

Harvard Bioscience Inc cash flow quality index by year from 2002 to 2014. Year-by-year earnings quality comparison for Harvard Bioscience Inc. For the full cash flow conversion analysis, see HBIO cash flow conversion.

Year Quality Index Operating CF (USD) Net Income YoY Change
2014 1.85x $4.35 Million $2.35 Million ▼ -45.7%
2012 3.40x $8.06 Million $2.37 Million ▲ +104.3%
2011 1.67x $6.35 Million $3.81 Million ▲ +157.6%
2010 0.65x $12.29 Million $19.02 Million ▼ -71.7%
2009 2.28x $16.51 Million $7.23 Million ▼ -58.5%
2008 5.50x $9.20 Million $1.67 Million ▲ +12.0%
2004 4.91x $11.44 Million $2.33 Million ▲ +931.6%
2003 0.48x $2.03 Million $4.26 Million ▼ -56.1%
2002 1.08x $799.46K $737.33K —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.